What is it?
Sanofi is committed to collaborating with partners to advance cutting-edge discoveries into transformative medicines that improve patient lives. The Sanofi Innovation Awards (iAwards) program, created in 2015, was designed to do just that. More than 26 top academic and medical centers in North America participate in this program to advance innovations in target identification and translational science into first-in-class therapeutic solutions.
About the program
- Seed funding of $125.000 USD
- Dedicated Sanofi Project Champion and resources (subject matter experts)
- A steppingstone to further collaboration
Who are we looking for?
Principal investigators from academic partner institutions developing cutting-edge therapeutic solutions in the following areas:
- Immuno- and molecular-oncology
- Immunology and inflammatory diseases
- Rare and neurological diseases
- Genomic medicine
- Precision medicine
- New therapeutic modalities
Get ready !
Our next call to be launched in early 2023
Our selection process
A fast process to select and start projects in less than 8 months
Week 0
Call launch
Jonathan A. Epstein"I am pleased by the continued partnership between the Perelman School of Medicine at the University of Pennsylvania and Sanofi, in particular the success of the Sanofi iAwards. Our investigators" appreciate the opportunity to collaborate with Sanofi scientists and leadeership on cutting-edge, scientific ideas - advancing the innovative work from concept to application. As a JSSC member, I am delighted to foster this partnership and support the program's grouwth, not only at Penn, but accorss the U.S."
Jonathan A. Epstein, M.D., Executive Vice Dean and Chief Scientific Officer, WIlliam Wikoff Smith Professor of MEdicine, Perelman School of Medecine at the University of Pennsylvania, Sanofi iAwards External Joint Scientific Steering Commitee Member
Isabelle Aubert“Thanks to the iAwards program, we joined forces with the bright team of scientists at Sanofi to propel the field of non-invasive gene delivery to the brain. It is incredibly stimulating and productive, generating exciting discoveries with translational potential. The collective knowledge and expertise made possible through this continued collaborative partnership could transform the future gene therapy for patients with neurological disorders.”
Isabelle Aubert, Senior Scientist, Biological Sciences, Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute Sunnybrook Research Institute, University of Toronto
Vijay Kuchroo“The program enables advancing scientifically novel yet risky projects, that if successful, could produce transformative medicines. The financial support, expertise and reagents from Sanofi as part of this collaboration is critical for advancing novel bench side discoveries to the clinic.”
Vijay Kuchroo, Ph.D., Samuel L. Wasserstrom professor of Neurology at Harvard medical School, Co-Director of the Center for Injection and Immunity, Brigham Research Institutes, Boston, Associate Member of the Broad Institute
Nicolas Nassar“The iAwards program is a fantastic opportunity and partnership to move forward a small molecule technology with a leading pharmaceutical company in the oncology space. The scientists involved with the Sanofi iAwards program are completely invested in the science and their insight is crucial to understanding the science and the technology.”
Nicolas Nassar, PhD, Cincinnati Children’s Hospital
Dr. Wayne Rowe"Our iAwards program collaborates with top academic innovators to quickly bring early-stage value creating projects to Sanofi’s research pipeline. About 40% of our iAwards projects convert into multi-year Sponsored Research Agreements that provide key medical solutions to the patient."
Dr. Wayne Rowe, Director of Sanofi’s iAwards Program
iAward recipients for the 2022 cycle
Changning Wang
Mass General Hospital
Francesca Bartolini
Columbia University
Nikolas Patsoukis
Beth Israel Deaconess Medical Center
Casey Maguire
Mass General Hospital
Eric Smith
Dana Farber Cancer Institute
Joe Zhou
Weill Cornell Medicine
Jonathan Schneck
Johns Hopkins Medicine
Daniel Tenen
Beth Israel Deaconess Medical Center
Rohit Chandwani
Weill Cornell Medicine
iAward Program Partners
Beth Israel Deaconess Medical Center
Boston Children’s Hospital
Brigham and Woman’s Hospital
California Institute of Technology
Cincinnati Children’s Hospital Medical Center
Columbia University
Dana Farber Cancer Institute
Harvard University
Johns Hopkins University
Massachusetts General Hospital
MD Andersons Cancer Center
New York University
Northeastern University
Sinai Health System
Stanford Medicine
Sunnybrook Research Institute
Ohio State University
Tufts University
University of California Los Angeles Technology Development Group
University of California San Francisco
University Health Network
University of Florida
University of Massachusetts Medical School
University of Pennsylvania
Vanderbilt University
Vanderbilt University Medical Center
Weill Cornell Medicine
For more information about North America partnerships,
contact SRI-NA@sanofi.com